China Resources Pharmaceutical Group Limited (FRA:640)
Germany flag Germany · Delayed Price · Currency is EUR
0.5600
+0.0050 (0.90%)
Last updated: May 13, 2025
-19.42%
Market Cap 3.59B
Revenue (ttm) 34.10B
Net Income (ttm) 440.83M
Shares Out n/a
EPS (ttm) 0.07
PE Ratio 8.14
Forward PE 7.33
Dividend 0.03 (5.54%)
Ex-Dividend Date May 28, 2025
Volume n/a
Average Volume 1,800
Open 0.5600
Previous Close 0.5550
Day's Range 0.5600 - 0.5600
52-Week Range 0.5250 - 0.8350
Beta n/a
RSI 50.46
Earnings Date May 2, 2025

About FRA:640

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovas... [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 72,700
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 640
Full Company Profile

Financial Performance

In 2024, FRA:640's revenue was 257.67 billion, an increase of 5.30% compared to the previous year's 244.70 billion. Earnings were 3.33 billion, a decrease of -13.57%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.